Innovative Solutions for Life Science Challenges

PROFESSIONAL SUMMARY

Scientist and biotechnology executive with significant expertise in molecular and cellular biology, combined with extensive experience leading laboratory operations, translational research, and scientific organizations. Proven track record of building and managing R&D environments, supporting complex laboratory infrastructure, and translating scientific innovation into applied technologies, including vaccines, antibody platforms, and biomaterials.

Experienced in laboratory operations management, including equipment oversight, vendor coordination, workflow optimization, and regulatory alignment (GLP/GMP principles and good documentation practices). Former founder and CEO with successful company acquisitions and a history of leading venture-backed and NIH-funded research programs. Recognized for strong leadership, cross-functional collaboration, and the ability to align scientific teams with operational excellence.

CORE COMPETENCIES

Laboratory Operations and Infrastructure Management

• GLP/GMP Principles and Regulatory Compliance 
• SOP Development and Inspection Readiness 
• Equipment Lifecycle Management including maintenance, calibration, and validation 
• Laboratory Safety, EHS compliance, audits, and training 
• Data integrity and good documentation practices 
• Budgeting, resource allocation, and cost control 
• Team leadership, mentorship, and staff development 

Scientific and Technical Expertise

• Molecular and cellular biology 
• Virology and viral pathogenesis 
• Immunology and cancer immunology 
• Antibody engineering and protein production 
• Recombinant viral systems and expression platforms 
• Vaccine development and adjuvant systems 
• Cell culture, tissue engineering, and biomaterials 
• Translational neuroscience and neurological disease 

PROFESSIONAL EXPERIENCE

Founder, CEO and CSO

Stephen Hall, PhD, Ltd (1998–2023)

Directed laboratory operations supporting antibody engineering and biomaterials research programs, including venture-backed and NIH-funded initiatives, with full responsibility for infrastructure, personnel, and scientific execution.

• Built and maintained laboratory operations supporting complex R&D programs in antibody engineering and biomaterials 
• Established SOPs and operational workflows that improved experimental consistency and reproducibility 
• Oversaw equipment selection, maintenance, and vendor relationships to ensure uninterrupted laboratory function 
• Managed budgets, procurement, and resource allocation to support efficient use of capital and materials 
• Led cross-functional coordination between scientific teams, external collaborators, and operational stakeholders 
• Company acquired in 2023 

Founder, CEO and CSO

Pentamer Pharmaceuticals, Inc. (1997–2002)

Founded and led a biotechnology company focused on vaccine development and immunological technologies, supported by venture financing and NIH SBIR funding.

• Established laboratory infrastructure supporting recombinant platforms and vaccine development programs 
• Directed day-to-day laboratory operations, including workflow design, resource allocation, and project execution 
• Secured venture funding and managed investor relationships and reporting 
• Led NIH-funded research initiatives focused on antibody display libraries and immunological technologies 
• Advanced antibody and vaccine technologies from early research through preclinical development 
• Built and led multidisciplinary scientific teams in a fast-paced startup environment 
• Positioned the company for successful acquisition by Johnson & Johnson Development Corporation and Robarts Research Institute      

POSTDOCTORAL RESEARCH EXPERIENCE

Research Fellow

Medical Biology Institute, now Avanir Pharmaceuticals (1996–1997)

• Conducted translational research in cancer immunology      
• Contributed to research programs bridging basic science and therapeutic application 

Postdoctoral Research Associate

The Scripps Research Institute (1995–1997)

• Conducted molecular and structural virology research 
• Developed recombinant viral systems for vaccine applications 
• Sole inventor of a patented vaccine platform technology that led to the formation of Pentamer Pharmaceuticals 

ACADEMIC APPOINTMENTS

Adjunct Professor, EPICS Program, Purdue University (2011–2012)
Adjunct Professor, Biomedical Engineering, University of South Dakota (2008–2010)
Adjunct Professor, Molecular and Cellular Biology, San Diego State University (1998–2000)

EDUCATION

Ph.D., Molecular and Cellular Biology
Purdue University, 1995
American Cancer Society Fellow

B.S., Chemistry
Grand Canyon University, 1990

EARLY RESEARCH AND TEACHING EXPERIENCE

Instructor, Molecular Neurobiology (Summer Programs)

Cold Spring Harbor Laboratory (1991–1993)

• Delivered intensive instruction in molecular neurobiology to advanced students and researchers 
• Led laboratory-based training in neuroscience techniques and experimental design 

Research Assistant, Department of Neurosurgery

Barrow Neurological Institute (1987–1990)

• Supported neurosurgical research programs focused on the chemistry of NMDA receptors in a baboon model of ischemic stroke
• Performed laboratory experiments, data collection, and analysis in a clinical research setting 

PATENTS AND FUNDING

Recombinant Nodavirus Compositions and Methods (Patent Family)

• U.S. Patent US6171591B1 
• International Patent Application WO1999029723A1 

NIH SBIR Grant, 1998
Development of Highly Diverse Antibody Display Libraries

Secured venture funding from Johnson & Johnson and GeneChem Technologies Venture Fund

SELECTED PUBLICATIONS

Harting, M. T., Cox, C. S., and Hall, S. G. (2009). Preclinical evidence for cellular therapy as a treatment for neurological disease. In V. K. Rajasekhar and M. C. Vemuri (Eds.), Regulatory Networks in Stem Cells. Totowa, NJ: Humana Press.

Zeigler, F., and Hall, S. G. (2007). Isolation of oligodendroglial cells from cultured neural stem and progenitor cells. Methods in Molecular Biology, 407, 323–331.

LEADERSHIP AND PROFESSIONAL DEVELOPMENT

• Founder of two biotechnology companies with successful acquisitions 
• Executive leadership in scientific strategy, operations, and team development 

MILITARY SERVICE

United States Army and Army National Guard (1973–1980)
Sergeant (E-5), Field Artillery

• Leadership role as Section Chief in a self-propelled artillery unit 
• Honorable discharge 
• Protected veteran status with a service-connected disability